CBD and other cannabinoids including THC have been known to ease cancer and chemotherapy related nausea, fatigue, pain, sleep deprivation, and depression. However, scientists and patients are wondering if different cannabinoids will have an affect on the cancer cells, and work to reduce tumors and encourage normal cell behavior. According to a 2013 study, many cannabinoids have pro-apoptotic and anti-proliferative properties which are known to affect cancer cell growth and metastasization.
While delta-9 THC has been used for years in medically legal states for cancer pain management, the psychoactive effects aren’t always wanted by patients. This is why more research is being done into what CBD can do for cancer, so patients can still have relief without feeling high. According to the American Cancer Society, delta-9 THC and other cannabinoids like CBD have been shown to kill or slow the growth of cancer cells in lab environments and animals test trials.
Testing cannabinoid treatments on human patients is in early stages in the clinical world, but there seems to be a lot of success in patients who use a combination of THC and CBD. The CBD specifically has been shown to slow or stop the growth of new cancer cells, while the THC will aid in shrinking existing tumors. There is also a lot of evidence showing that using full spectrum or full plant products tends to be more effective than an isolate CBD product, particularly in Leukemia patients. This is mainly due to the fact that different cannabinoids have different therapeutic properties, so using them together can help patients suffering from cancer in multiple ways. While cannabinoid therapy research is still new, it is showing a lot of promise in the clinical world.
“CBD: A patient’s guide to medicinal cannabis”, Leonard Leinow and Juliana Birnbaum,